A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma
Clinical trial NCT04088500 · TERMINATED
Trial details
- NCT number
- NCT04088500
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2021-11-15
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.